$LUNG Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.19 up 44.12% YoY
• Reported revenue of $22.84M up 6.23% YoY
• Pulmonx expects full-year 2026 revenue of $90M to $92M, gross margin of approximately 77%, and total operating expenses of $108M to $109M, including approximately $14M of non-cash stock-based compensation.